Quarterly report pursuant to Section 13 or 15(d)

Segments (Tables)

v3.3.0.814
Segments (Tables)
9 Months Ended
Sep. 30, 2015
Segment Reporting [Abstract]  
Information regarding our geographic activities
Information regarding our operations and assets for our operating segments and the unallocated corporate operations as well as geographic information are as follows:
 
For the three months ended September 30,
 
For the nine months ended September 30,
(In thousands)
2015
 
2014
 
2015
 
2014
Revenue from services:
 
 
 
 
 
 
 
Pharmaceuticals
$
160

 
$

 
$
192

 
$

Diagnostics
103,739

 
2,422

 
107,597

 
6,426

Corporate
20

 
60

 
140

 
180

 
$
103,919

 
$
2,482

 
$
107,929

 
$
6,606

Product revenues:
 
 
 
 
 
 
 
Pharmaceuticals
$
20,765

 
$
17,291

 
$
59,066

 
$
58,510

Diagnostics

 

 

 

Corporate

 

 

 

 
$
20,765

 
$
17,291

 
$
59,066

 
$
58,510

Revenue from transfer of intellectual property:
 
 
 
 
 
 
 
Pharmaceuticals
$
18,350

 
$

 
$
48,552

 
$
285

Diagnostics

 

 

 
191

Corporate

 

 

 

 
$
18,350

 
$

 
$
48,552

 
$
476

Operating (loss) income:
 
 
 
 
 
 
 
Pharmaceuticals
$
5,300

 
$
(34,480
)
 
$
(36,861
)
 
$
(71,421
)
Diagnostics
(1,961
)
 
(6,738
)
 
(17,961
)
 
(20,621
)
Corporate
(11,562
)
 
(6,384
)
 
(34,444
)
 
(19,557
)
Less: Operating loss attributable to noncontrolling interests

 
(599
)
 
(1,281
)
 
(1,762
)
 
$
(8,223
)
 
$
(48,201
)
 
$
(90,547
)
 
$
(113,361
)
Depreciation and amortization:
 
 
 
 
 
 
 
Pharmaceuticals
$
2,775

 
$
2,020

 
$
6,902

 
$
6,061

Diagnostics
9,602

 
1,717

 
13,103

 
5,136

Corporate
22

 
31

 
68

 
72

 
$
12,399

 
$
3,768

 
$
20,073

 
$
11,269

Net loss from investment in investees:
 
 
 
 
 
 
 
Pharmaceuticals
$
(3,502
)
 
$
(60
)
 
$
(6,067
)
 
$
(2,486
)
Diagnostics

 

 

 

Corporate

 

 

 

 
$
(3,502
)
 
$
(60
)
 
$
(6,067
)
 
$
(2,486
)
Revenues:
 
 
 
 
 
 
 
United States
$
104,358

 
$
2,482

 
$
109,359

 
$
7,082

Ireland
22,308

 

 
53,807

 

Chile
7,779

 
7,622

 
22,929

 
22,758

Spain
3,447

 
4,414

 
12,303

 
16,230

Israel
4,154

 
3,710

 
14,309

 
14,563

Mexico
988

 
1,528

 
2,840

 
4,905

Other

 
17

 


54

 
$
143,034

 
$
19,773

 
$
215,547

 
$
65,592


(In thousands)
September 30,
2015
 
December 31,
2014
Assets:
 
 
 
Pharmaceuticals
$
1,262,373

 
$
1,064,498

Diagnostics
1,287,854

 
108,072

Corporate
465,626

 
95,094

 
$
3,015,853

 
$
1,267,664

Goodwill:

 

Pharmaceuticals
$
237,518

 
$
173,327

Diagnostics
523,716

 
50,965

Corporate

 

 
$
761,234

 
$
224,292